news
Scientists will develop and test promising new molecules for targeting…
19 April 2017 | By Niamh Marriott (Drug Target Review)
Scientists will develop and test promising new molecules for targeting RAS, one of the most common driving mutations in aggressive, hard to treat cancers including pancreatic and lung cancer.